STEVEN CRANE — Lobbyist Profile | Poliscope

STEVEN CRANE

Reported covered position: Subcommittee Clerk, House Appropriations Committee

Filings

141

Clients

Firms

Years active

2012–2026

Associated filing income

$5,175,000

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
SIGA TECHNOLOGIES	58	2012–2026
ALZHEIMER'S ASSOCIATION	46	2012–2023
REGENERON PHARMACEUTICALS, INC.	31	2019–2026
CHILD MIND INSTITUTE	6	2012–2013

Lobbying firms

Firm	Filings	Years
CRANE STRATEGIES	141	2012–2026

Bills explicitly cited in this lobbyist’s assigned issues (3)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 3299

Strengthening Public Health Emergency Response Act of 2016

Client: SIGA TECHNOLOGIES · Firm: CRANE STRATEGIES

Open original LDA filing ↗

Cited source text

S. 2055 Medical Countermeasure Innovation Act of 2016, issues relating to Priority Review Vouchers. H.R. 6 21st Century Cures Act, issues relating to Priority Review Vouchers. H.R. 3299 Strengthening Public Health Emergency Response Act of 2015, issues relating to Priority Review Vouchers.

H.R. 6

21st Century Cures Act

Client: SIGA TECHNOLOGIES · Firm: CRANE STRATEGIES

Open original LDA filing ↗

Cited source text

S. 2055 Medical Countermeasure Innovation Act of 2016, issues relating to Priority Review Vouchers. H.R. 6 21st Century Cures Act, issues relating to Priority Review Vouchers. H.R. 3299 Strengthening Public Health Emergency Response Act of 2015, issues relating to Priority Review Vouchers.

Original LDA source filings (100)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2026 · second_quarter · Q2

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense and Medicare prescription drug funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2026 · second_quarter · Q2

Firm income: $80,000Client expense: —Open original LDA filing ↗

Source: Senate LDA

Show 96 more original filings

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2025 · fourth_quarter · Q4

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2025 · fourth_quarter · Q4

Firm income: $80,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2025 · third_quarter · Q3

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2025 · third_quarter · Q3

Firm income: $80,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2025 · second_quarter · Q2

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2025 · second_quarter · Q2

Firm income: $70,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2025 · first_quarter · Q1

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2025 · first_quarter · Q1

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2024 · fourth_quarter · Q4

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense and COVID-19 funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2024 · fourth_quarter · Q4

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2024 · third_quarter · Q3

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense and COVID-19 funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2024 · third_quarter · Q3

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2024 · second_quarter · Q2

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense and COVID-19 funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2024 · second_quarter · Q2

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2024 · first_quarter · Q1

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense and COVID-19 funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2024 · first_quarter · Q1

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2023 · fourth_quarter · Q4

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense and COVID-19 funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2023 · fourth_quarter · Q4

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2023 · third_quarter · Q3

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense and COVID-19 funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2023 · third_quarter · Q3

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2023 · second_quarter · 2T

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2023 · second_quarter · Q2

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense and COVID-19 funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2023 · second_quarter · Q2

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2023 · first_quarter · Q1

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense and COVID-19 funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2023 · first_quarter · Q1

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2023 · first_quarter · Q1

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2022 · fourth_quarter · Q4

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Coronavirus therapeutic funding; biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2022 · fourth_quarter · Q4

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2022 · fourth_quarter · Q4

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2022 · third_quarter · Q3

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Coronavirus therapeutic funding; biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2022 · third_quarter · Q3

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2022 · third_quarter · Q3

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2022 · second_quarter · Q2

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Coronavirus therapeutic funding; biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2022 · second_quarter · Q2

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2022 · second_quarter · Q2

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2022 · first_quarter · Q1

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Coronavirus therapeutic funding; biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2022 · first_quarter · Q1

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2022 · first_quarter · Q1

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2021 · fourth_quarter · Q4

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Coronavirus therapeutic funding; biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2021 · fourth_quarter · Q4

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2021 · fourth_quarter · Q4

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2021 · third_quarter · Q3

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2021 · third_quarter · Q3

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2021 · third_quarter · Q3

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Coronavirus therapeutic funding; biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2021 · second_quarter · Q2

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Coronavirus therapeutic funding; biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2021 · second_quarter · Q2

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2021 · second_quarter · Q2

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2021 · first_quarter · Q1

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2021 · first_quarter · Q1

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2021 · first_quarter · Q1

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Coronavirus therapeutic funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2020 · fourth_quarter · Q4

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding; coronavirus supplemental funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2020 · fourth_quarter · Q4

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2020 · fourth_quarter · Q4

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2020 · third_quarter · Q3

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding; coronavirus supplemental funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2020 · third_quarter · Q3

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2020 · third_quarter · Q3

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2020 · second_quarter · Q2

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding; coronavirus supplemental funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2020 · second_quarter · Q2

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding; economic stimulus legislation pertaining to non-profits

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2020 · second_quarter · Q2

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2020 · first_quarter · Q1

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding; coronavirus supplemental funding

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2020 · first_quarter · Q1

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding; economic stimulus legislation pertaining to non-profits

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2020 · first_quarter · Q1

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2019 · fourth_quarter · Q4

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2019 · fourth_quarter · Q4

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2019 · fourth_quarter · Q4

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2019 · third_quarter · Q3

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2019 · third_quarter · Q3

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2019 · third_quarter · Q3

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2019 · second_quarter · Q2

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2019 · second_quarter · Q2

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2019 · second_quarter · Q2

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2019 · first_quarter · Q1

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2019 · first_quarter · Q1

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2019 · first_quarter · Q1

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

REGENERON PHARMACEUTICALS, INC. via CRANE STRATEGIES

2019 · first_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2018 · fourth_quarter · Q4

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2018 · fourth_quarter · Q4

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2018 · third_quarter · Q3

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2018 · third_quarter · Q3

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2018 · second_quarter · Q2

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2018 · second_quarter · Q2

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2018 · first_quarter · Q1

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2018 · first_quarter · Q1

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2017 · fourth_quarter · Q4

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2017 · fourth_quarter · Q4

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2017 · third_quarter · Q3

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2017 · third_quarter · Q3

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2017 · second_quarter · Q2

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2017 · second_quarter · Q2

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2017 · first_quarter · Q1

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2017 · first_quarter · Q1

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2016 · fourth_quarter · Q4

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

S. 2055 Medical Countermeasure Innovation Act of 2016, issues relating to Priority Review Vouchers. H.R. 6 21st Century Cures Act, issues relating to Priority Review Vouchers. H.R. 3299 Strengthening Public Health Emergency Response Act of 2015, issues relating to Priority Review Vouchers.

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2016 · fourth_quarter · Q4

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2016 · third_quarter · Q3

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

SIGA TECHNOLOGIES via CRANE STRATEGIES

2016 · third_quarter · Q3

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Biodefense funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ALZHEIMER'S ASSOCIATION via CRANE STRATEGIES

2016 · second_quarter · Q2

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Alzheimer's disease research, care and supportive services funding

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE